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ABSTRACT 
PCR involves a repeating cycle of replication to amplify small segments of deoxyribonucleic acid (DNA). A novel application of 
this technique is microbial identification in infectious keratitis, one of the leading causes of blindness in the world. PCR is more 
sensitive than biological stains and culture, which are considered the current gold standards for diagnosing infectious keratitis. 
The diagnosis and treatment of infectious keratitis cost the United States millions of dollars in health expenditure. PCR may 
help offset that cost by allowing for individualized disease management and screening for multiple antibiotic-resistant genes. 
While beneficial, PCR demonstrates lower specificity rates compared to culture and stain, indicating its shortcomings; this can 
be overcome by performing PCR after narrowing the pool of potential microorganisms. This article examines the clinical utility 
of PCR in cases of infectious keratitis by evaluating its reliability, validity, associated costs, and indications. 
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INTRODUCTION
Infectious keratitis is characterized by inflammation of 
the cornea due to infection by bacteria, fungi, amebae, 
and viruses [1]. It is imperative to diagnose and treat 
these infections as soon as possible due to the potential 
for vision loss. Corneal opacification, which is a sequela 
of infectious keratitis, is the fourth leading cause of 
blindness in the world [2, 3]. Trauma with subsequent 
microbial infiltration of the cornea accounts for up to 5% 
of all cases of blindness in the developing world [4, 5]. 
Currently, the gold standard diagnostic tests are Gram 
stain and culture [2, 4]. Microbial culture, in particular, 
has high specificity but is a relatively insensitive method 
[6]. However, the advent of the polymerase chain 
reaction (PCR) has led to multiple reports showing 
superior sensitivity compared to traditional methods. 
Commonly used staining and culturing media include the 
Giemsa stain, Gram stain, blood agar, and Sabouraud 
agar, although others are available depending on the 
targeted microorganism [4]. Culturing can take several 
days to show a diagnosis; specifically, bacterial cultures 
can take 2-4 days, and fungal cultures can take 2-10 days 
[7]. Traditional viral cultures can take days to weeks 
depending on the virus, although more modern culturing 
methods can decrease the time to 24 hours [8]. On the 
other hand, staining of corneal scrapings can provide 
immediate identification of the causative agent [2].  
The purpose of this article is to examine the practical 
applications, diagnostic validity, and cost-effectiveness of 
PCR in infectious keratitis. 
METHODS 
To find information on PCR and infectious keratitis, a 
literature search was performed using the following 
sources: PubMed, Google Scholar, and Scopus with the 
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keywords “PCR and infectious keratitis,” “polymerase 
chain reaction keratitis,” “PCR and bacterial keratitis,” 
“PCR and fungal keratitis,” “PCR and viral keratitis,” and 
“PCR and keratitis.” Reference lists of these articles were 
used to find additional articles. There were no language 
restrictions. Publications were drawn between the dates 
of 1990-2019. 
PCR Advantages 
PCR involves repeated cycles of denaturation, 
amplification, and replication, in which segments of 
deoxyribonucleic acid (DNA) are continuously multiplied. 
Specific DNA primers are employed to indicate the 
presence of the microorganism in question [9]. PCR has 
also been used throughout the field of molecular biology, 
helping researchers clone and sequence genes for the 
detection of mutations [10]. It has more recently become 
a modality for detecting microbial agents, requiring only 
a small sample for analysis [7, 9]. Currently, PCR is just a 
confirmatory test with its use limited to the diagnosis of 
herpetic keratitis [4]. The PCR procedure takes 
approximately 4-8 hours, which is about three times 
faster than those of cultures [7, 11]. A particular type, 
known as multiplex PCR, can amplify multiple sequences 
of DNA in one reaction. It has been used to detect 
several different antibiotic genes found in methicillin-
resistant staph aureus (MRSA) [12, 13], earning the 
distinction as the gold standard for the detection of 
MRSA [14]. 
Multiple reports have shown PCR to be comparable, if 
not better than, traditional staining and culturing [4, 15-
17]. Gram staining can correctly identify bacteria and 
fungi 60-75% and 35-90% of the time, respectively [2, 
18]. Cultures have a similar result, identifying 59% of 
bacteria and 45% of fungi [18]. The sensitivities produced 
by these tests are relatively low and show considerable 
variation, leaving room for diagnostic improvement. 
Polymerase chain reaction demonstrated higher 
positivity rates and sensitivity than culture and stains for 
both bacteria and fungi [7, 15]. Zhao et al. reported the 
positive detection rate of PCR as 83% and 85% for 
bacterial and fungal keratitis, respectively. For fungal 
keratitis, this rate was greater than the positive detection 
rate for culture (35%) and stain (65%) [15]. Overall, 
studies have reported PCR having a higher sensitivity for 
infectious keratitis compared to culture (98% versus 
47%), but a slightly lower specificity (83% versus 100%) 
[15]. In regards to Acanthamoeba keratitis, PCR displayed 
higher sensitivity (33% vs. 71%) and comparable 
specificity (100%) to culture [16]. In summary, PCR 
appears to show superior sensitivities but comparable 
specificities for the identification of bacteria, fungi, and 
Acanthamoeba in infectious keratitis (Table 1). 
PCR Disadvantages 
PCR has a few shortcomings (Table 1). Its specificity is 
potentially lower than culturing and staining, implying an 
increased risk for false positives. Since specific primers 
are used to identify different microorganisms, physicians 
often need to list potential microorganisms before 
performing selective PCR [17]. For example, 16S bacterial 
DNA primers and 18S fungal DNA primers are the most 
common primers selected for these causes of infectious 
keratitis. Due to genetic similarities between different 
bacteria and fungi, common DNA may be amplified 
leading to false positives by the detection of normal flora 
of the corneal external environment [4]. Kim et al. 
reported another problem when they discovered 
organisms unrelated to human infection in their control 
PCR samples. They attributed this finding to airborne 
contamination due to their samples being shipped from 
India [6]. However, airborne contamination is an 
infrequent occurrence in PCR, implying that either this 
was an isolated finding or that keratitis samples are more 
likely to be contaminated [19]. Cross contamination is 
also an issue in culture and staining, but perhaps the 
sensitive nature of PCR increases that risk. Moreover, 
different microorganisms populate distinct geographical 
areas [20]. In a ten year study, Ting et al. found that 
MRSA-related keratitis was much lower in their region 
compared to other countries, suggesting that clinicians 
take locality into account when requesting and 
interpreting PCR results [20]. 
 
Table 1: Advantages and Disadvantages for the Use of Polymerase 
Chain Reaction (PCR) in Identifying Causative Agents in Infectious 
Keratitis. 
Advantages of PCR Disadvantages of PCR 
High sensitivity compared to 
culture and staining 
Potentially lower specificity 
compared to culture and staining 
Ability to test for anti-
microbial resistance 
Need for narrow list of causative 
agents to use specific primers 
Quickly performed in 4-8 
hours 
Possibility of amplifying normal 
flora from corneal scrapings 
Shown to be more cost-
effective with selective use 
than culture and staining 
Becomes less cost-effective when 
performed with a multi-organism 
PCR approach 
Increased ability to detect less 
common organisms such as 
viruses 
Supply costs, machinery fees, 
training expenses 
Cost-Effectiveness 
Culturing and staining have been used for decades in 
large part due to their ease and accessibility. Staining 
and culturing are both inexpensive, with many of the 
materials widely available. In contrast, PCR requires 
trained technicians and specific machinery. Clinicians 
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who wish to analyze PCR off-site can send samples to 
an outside laboratory, which can cost from 15 USD to 
30 USD per microorganism tested [21]. The general 
approach to PCR commonly includes testing panels on 
a wide array of organisms using universal primers [22]. 
The cost per sample from this broad-range PCR 
approach can be hundreds of dollars [22]. The U.S. 
spends USD 175 million in total health expenditure 
annually on medical, non-surgical interventions of 
infectious keratitis [1, 4]. This value only includes costs 
associated with outpatient and emergency 
department visits that did not lead to subsequent 
hospital admissions, resulting in a significant 
underestimation of the expenditure [1]. Therefore, 
PCR must also be cost-effective to be widely used in 
the diagnosis of infectious keratitis.  
A cost-effective analysis comparing multiplex PCR to 
blood culturing of Candida infections showed a lower 
overall cost of PCR along with better health outcomes 
[17]. The estimated cost savings for the institution 
performing the analysis was 326,400 USD [17]. Other 
reports have suggested similar findings [23-25]. The 
cost to treat infectious keratitis significantly varies 
depending on the cause and severity of the infection 
[23]. By quick identification of the offending agent, 
PCR can lead to earlier treatment and reduction in 
vision loss, indirectly reducing the overall cost 
associated with infectious keratitis [23]. For example, 
PCR shows higher specificity for M. tuberculosis than 
staining, resulting in decreased costs by treating fewer 
misdiagnosed patients [24]. When used in conjunction 
with acid-fast stain to identify the causative agent, 
PCR is almost four times more cost-effective compared 
to a combination of stain and culture [25]. Infectious 
keratitis predominantly affects developing countries. 
Thirty times more people in India suffer from the 
disease each year compared to the United States [4, 
5]. Even with the additional costs of performing PCR, 
these results suggest that a centralized lab performing 
PCR may be beneficial for countries disproportionately 
affected by infectious keratitis. 
PCR Use in Antibiotic Resistance 
Empiric therapy for infectious keratitis using broad-
spectrum antimicrobials has led to antimicrobial 
resistance [4]. For example, in the case of Candidal 
keratitis, this type of clinical approach has led to 
antifungal resistance and increased expenditure [17]. 
The trend of antimicrobial resistance is especially 
evident in the case of bacterial keratitis. Cases of 
moxifloxacin resistance, a broad spectrum 
fluoroquinolone, has been documented in 26% of 
bacterial keratitis patients at a clinic in the United 
States [4]. In India, 60-66% of the methicillin-sensitive 
Staph aureus tested were resistant to moxifloxacin [26]. 
A benefit of PCR is the ability to test for multi-drug 
resistance. As shown with MRSA, a strength of 
multiplex PCR is the ability to test for multiple 
antibiotic genes with one sample, guiding specific 
antimicrobial treatment while reducing the chance of 
developing drug resistance [14]. Interestingly, another 
way PCR can evaluate sensitivity to antimicrobials is by 
quantitative analysis of viral load after treatment. 
Inoue et al. report a case of Herpes Simplex Virus that 
showed persistent levels of viral DNA on PCR after 
treatment with Acyclovir. This led physicians to 
prescribe trifluorothymidine [27]. 
CONCLUSION 
The future of PCR appears promising. New versions of 
the classic PCR have drastically shortened the time 
required to reach a diagnosis while also reducing the 
number of false positives [27-29]. Even in its present 
state, PCR has shown to match and even exceed the gold 
standard (culture and staining) in certain performance 
measures, such as sensitivity for the detection of 
microorganisms in infectious keratitis. The widely used 
broad-range PCR assay may distinguish among the 
various microbes. However, clinicians who wish to 
confirm clinical impression and consider cost-
effectiveness may narrow the differential of causative 
organisms when sending samples to laboratories for PCR 
analysis.  
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